IPP Bureau
GSK bets big on oncology with $10.6 billion Nuvalent acquisition
By IPP Bureau - June 10, 2026
Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio
Ten years on, PMSMA continues to shape safer motherhood in India
By IPP Bureau - June 10, 2026
7.5 crore antenatal check-ups and 1.2 crore high-risk pregnancies identified under flagship programme as maternal and neonatal mortality declines
AmMax Bio licenses Lonza’s ADC tech to advance AML candidate AMB-104
By IPP Bureau - June 10, 2026
The company gets access to Lonza’s clinically validated SYNtecan linker-payload platform as it prepares an IND filing for its acute myeloid leukemia therapy in 2027
Johnson & Johnson to acquire Firefly Bio in $1 billion oncology push
By IPP Bureau - June 10, 2026
The acquisition reflects Johnson & Johnson’s push to strengthen its position in antibody engineering and next-generation oncology modalities
Viyash Scientific to acquire Italy’s BioForLife for Rs. 188 crore
By IPP Bureau - June 10, 2026
The acquisition of Milan-based company will strengthen subsidiary Alivira Animal Health’s presence in Europe
Hoola Health raises $5 million to expand child-centric paediatric care
By IPP Bureau - June 10, 2026
Bengaluru-based startup will use the fresh capital to enter new markets, enhance technology capabilities, and scale its integrated care model
HAB Pharma targets Rs. 3,000 crore revenue by 2030
By IPP Bureau - June 10, 2026
Consolidated entity plans to strengthen specialty pharmaceutical offerings, expand manufacturing capacity, and accelerate global market penetration across emerging regions
Ajanta Pharma elevates Atul Galgalikar as Vice President for international business
By IPP Bureau - June 10, 2026
Pharma industry veteran brings more than two decades of experience in sales, marketing, business development, and global market expansion to his new leadership role
Remidio secures Gates Foundation grant to advance AI-powered retinal screening
By IPP Bureau - June 10, 2026
Funding will support the expansion of Remidio’s Oculomics platform to identify early signs of pre-eclampsia, anemia and gestational diabetes through retinal imaging, targeting underserved communities
Cipla elevates Manoj Dimri as Group Business Head
By IPP Bureau - June 10, 2026
Pharma industry veteran brings extensive experience in commercial strategy, business growth, and market leadership to his expanded role at Cipla
Pharma industry poised to reach US$ 130 billion by 2030: Joint Secretary, Department of Commerce
By IPP Bureau - June 10, 2026
Mohit Yadav reaffirmed government's commitment to improve competitiveness, enhance export capabilities and support the country's transition from volume-driven to value-driven exports
FDA greenlights Lilly’s EBGLYSS for ultra-low-frequency dosing in eczema breakthrough
By IPP Bureau - June 10, 2026
The move makes EBGLYSS the only therapy offering as few as six maintenance injections per year
DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability excellence
By IPP Bureau - June 10, 2026
Recognition places pharmaceutical excipients leader among the top 5% of companies globally, highlighting progress in emissions reduction, responsible sourcing, and sustainable supply chain practices
DePuy Synthes launches AI-powered hip surgery navigation system to streamline operating room workflow
By IPP Bureau - June 10, 2026
The company says the goal is to improve consistency and efficiency in total hip arthroplasty (THA) as demand for the procedure continues to surge
Oval Fertility and Merck India partner to advance access to high-quality fertility care
By IPP Bureau - June 10, 2026
Strategic collaboration aims to strengthen clinical capabilities, enhance patient experience and improve fertility treatment outcomes through scientific expertise, technology and data-driven care
